WeSearch

CRISPR makes prostate cancer vulnerable to immunotherapy

·6 min read · 0 reactions · 0 comments · 8 views
#crispr#makes#prostate#cancer#vulnerable
CRISPR makes prostate cancer vulnerable to immunotherapy
TL;DR · WeSearch summary

Science News from research organizations CRISPR makes prostate cancer vulnerable to immunotherapy Date: July 26, 2026 Source: University of Rochester Medicine Summary: Scientists used CRISPR to make prostate cancer cells easier for the immune system to detect and destroy. The experimental treatment dramatically improved the effects of immunotherapy in mice and may offer hope for other hard-to-treat tumors. Share: Facebook Twitter Pinterest LinkedIN Email FULL STORY A new CRISPR tool could transform hidden prostate tumors into targets the immune system can attack.

Key facts
About this source

ScienceDaily files mainly under science. We currently carry 82 of its stories.

Original article
ScienceDaily
Read full at ScienceDaily →
Opening excerpt (first ~120 words) tap to expand

Science News from research organizations CRISPR makes prostate cancer vulnerable to immunotherapy Date: July 26, 2026 Source: University of Rochester Medicine Summary: Scientists used CRISPR to make prostate cancer cells easier for the immune system to detect and destroy. The experimental treatment dramatically improved the effects of immunotherapy in mice and may offer hope for other hard-to-treat tumors. Share: Facebook Twitter Pinterest LinkedIN Email FULL STORY A new CRISPR tool could transform hidden prostate tumors into targets the immune system can attack. Credit: Shutterstock Prostate cancer is notoriously difficult to treat with immunotherapy, a type of cancer treatment that helps the immune system identify and destroy tumors.

Excerpt limited to ~120 words for fair-use compliance. The full article is at ScienceDaily.

Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from ScienceDaily